The effect of the partial dopamine agonist terguride on negative symptoms in schizophrenics.
Olbrich
R
R
Central Institute of Mental Health, Mannheim, FRG.
Schanz
H
H
D000328:Adult; D015259:Dopamine Agents / Q000627:therapeutic use*; D004873:Ergolines / Q000627:therapeutic use*; D006801:Humans; D008090:Lisuride / Q000031:analogs & derivatives / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology
D015259:Dopamine Agents; D004873:Ergolines; C006208:dironyl; D008090:Lisuride